Whereas mouse myelomas that secrete IgA half-molecules have been shown to arise in vivo, their origin has not been definitely established. We show that somatic variants secreting phenotypically similar molecules can arise directly from the normal IgA-secreting myelomas S107 and W3082. In addition to being improperly assembled, the variant proteins have distinct carboxy-terminal deletions and an aberrant heavy-light chain disulfide bond. For at least one of the variants, variable region serology and affinity for hapten are both unaffected by these changes. Southern and Northern blot analyses indicate normal size DNA restriction fragments and mRNA, suggesting premature termination as the mechanism of deletion. These results are discussed in relation to possible mutational hot spots and long-range interdomain interactions.
Skip Nav Destination
Article navigation
1 November 1981
Article|
November 01 1981
Somatically generated mouse myeloma variants synthesizing IgA half-molecules.
D J Zack
,
S L Morrison
,
W D Cook
,
W Dackowski
,
M D Scharff
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1981) 154 (5): 1554–1569.
Citation
D J Zack, S L Morrison, W D Cook, W Dackowski, M D Scharff; Somatically generated mouse myeloma variants synthesizing IgA half-molecules.. J Exp Med 1 November 1981; 154 (5): 1554–1569. doi: https://doi.org/10.1084/jem.154.5.1554
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement